| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analysis of aberrant transcription of TSG101 in hepatocellular carcinomas
|
Chen, Y.-J
|
|
1999
|
35 |
2 |
p. 302-308
7 p.
|
artikel
|
| 2 |
Applicability of the Health Utilities Index to a Population of Childhood Survivors of Central Nervous System Tumours in the U.K.
|
Glaser, A.W
|
|
1999
|
35 |
2 |
p. 256-261
6 p.
|
artikel
|
| 3 |
Carbonyl reductase and NADPH cytochrome P450 reductase activities in human tumoral versus normal tissues
|
López de Cerain, A
|
|
1999
|
35 |
2 |
p. 320-324
5 p.
|
artikel
|
| 4 |
Correspondence
|
|
|
1999
|
35 |
2 |
p. 327-
1 p.
|
artikel
|
| 5 |
Correspondence
|
|
|
1999
|
35 |
2 |
p. 326-
1 p.
|
artikel
|
| 6 |
Correspondence
|
|
|
1999
|
35 |
2 |
p. 325-
1 p.
|
artikel
|
| 7 |
Cytostatic concentrations of anticancer agents do not affect telomerase activity of leukaemic cells in vitro
|
Akiyama, M
|
|
1999
|
35 |
2 |
p. 309-315
7 p.
|
artikel
|
| 8 |
Does biomodulation of 5-fluorouracil improve results?
|
Sobrero, A.F
|
|
1999
|
35 |
2 |
p. 186-189
4 p.
|
artikel
|
| 9 |
Does biomodulation of 5-fluorouracil improve results?
|
Herrmann, R
|
|
1999
|
35 |
2 |
p. 189-192
4 p.
|
artikel
|
| 10 |
Does biomodulation of 5-Fluorouracil improve results?
|
Rischin, D
|
|
1999
|
35 |
2 |
p. 192-194
3 p.
|
artikel
|
| 11 |
Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patients 1 Accepted as a poster presentation to the 34th Annual Meeting of the American Society of Clinical Oncology, May 1998, Los Angeles, U.S.A. 1
|
Bajetta, E
|
|
1999
|
35 |
2 |
p. 208-213
6 p.
|
artikel
|
| 12 |
Editorial
|
|
|
1999
|
35 |
2 |
p. 171-172
2 p.
|
artikel
|
| 13 |
Effects of paclitaxel with or without cremophor EL on cellular clonogenic survival and apoptosis
|
Engblom, P
|
|
1999
|
35 |
2 |
p. 284-288
5 p.
|
artikel
|
| 14 |
Enhanced apoptosis correlates with poor survival in patients with laryngeal cancer but not with cell proliferation, bcl-2 or p53 expression
|
Hirvikoski, P.
|
|
1999
|
35 |
2 |
p. 231-237
7 p.
|
artikel
|
| 15 |
Erratum
|
|
|
1999
|
35 |
2 |
p. 328-
1 p.
|
artikel
|
| 16 |
Evaluation of the replication error phenotype in relation to molecular and clinicopathological features in hereditary and early onset colorectal cancer
|
Capozzi, E
|
|
1999
|
35 |
2 |
p. 289-295
7 p.
|
artikel
|
| 17 |
Familial and hereditary prostate cancer in southern Sweden. A population-based case–control study
|
Bratt, O
|
|
1999
|
35 |
2 |
p. 272-277
6 p.
|
artikel
|
| 18 |
Health-related quality of life in survivors of tumours of the central nervous system in childhood—a preference-based approach to measurement in a cross-sectional study 1 Presented in part to the meetings of the International Society of Pediatric Oncology (SIOP) in Paris, September 1994 and Montevideo, October 1995. 1
|
Barr, R.D
|
|
1999
|
35 |
2 |
p. 248-255
8 p.
|
artikel
|
| 19 |
Increased incidence of tongue cancer after primary radiotherapy for nasopharyngeal carcinoma—the possibility of radiation carcinogenesis
|
Teo, P.M.L
|
|
1999
|
35 |
2 |
p. 219-225
7 p.
|
artikel
|
| 20 |
Microsatellite instability: impact on cancer progression in proximal and distal colorectal cancers
|
Jernvall, P
|
|
1999
|
35 |
2 |
p. 197-201
5 p.
|
artikel
|
| 21 |
Molecular genetics, natural history and the demise of childhood leukaemia
|
Greaves, M.
|
|
1999
|
35 |
2 |
p. 173-185
13 p.
|
artikel
|
| 22 |
Mutations in mitochondrial control region DNA in gastric tumours of Japanese Patients
|
Tamura, G
|
|
1999
|
35 |
2 |
p. 316-319
4 p.
|
artikel
|
| 23 |
Onapristone, a progesterone receptor antagonist, as first-line therapy in primary breast cancer
|
Robertson, J.F.R
|
|
1999
|
35 |
2 |
p. 214-218
5 p.
|
artikel
|
| 24 |
p53 gene mutations and p21 protein expression induced independently of p53, by TGF-β and γ-rays in squamous cell carcinoma cells
|
Yoneda, K
|
|
1999
|
35 |
2 |
p. 278-283
6 p.
|
artikel
|
| 25 |
Plasma and salivary pharmacokinetics of 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer receiving 5-FU bolus plus continuous infusion with high-dose folinic acid
|
Joulia, J.M
|
|
1999
|
35 |
2 |
p. 296-301
6 p.
|
artikel
|
| 26 |
Prevention of Lung Cancer by Long-term Use of Alternative Nicotine Delivery Systems?
|
Kunze, U
|
|
1999
|
35 |
2 |
p. 195-196
2 p.
|
artikel
|
| 27 |
Prognostic significance of p53 codon 72 polymorphism in lung carcinomas
|
Wang, Y.-C
|
|
1999
|
35 |
2 |
p. 226-230
5 p.
|
artikel
|
| 28 |
Rationale for randomised trials of prostate cancer screening
|
|
|
1999
|
35 |
2 |
p. 262-271
10 p.
|
artikel
|
| 29 |
Reduction of chemotherapy-induced side-effects by parenteral glutamine supplementation in patients with metastatic colorectal cancer
|
Decker-Baumann, C
|
|
1999
|
35 |
2 |
p. 202-207
6 p.
|
artikel
|
| 30 |
The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38)
|
Sprangers, M.A.G
|
|
1999
|
35 |
2 |
p. 238-247
10 p.
|
artikel
|
Tijdschrift beschrijving